SCHEMBL7387346

SCHEMBL7387346

CCC(C)C(N)(N)C(=O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.35
MEN1 O00255 1/20 0.35
ALDH1A1 P00352 1/20 0.35
THRB P10828 1/20 0.35
KMT2A Q03164 1/20 0.35
KIF11 P52732 1/20 0.34
ARG1 P05089 2/20 0.33
ARG2 P78540 2/20 0.33
CYP2D6 P10635 1/20 0.33
GRM2 Q14416 2/20 0.32
GRM3 Q14832 2/20 0.32
SLC1A3 P43003 1/20 0.32
SLC1A2 P43004 1/20 0.32
SLC1A1 P43005 1/20 0.32
GGT1 P19440 1/20 0.31
GABRP O00591 2/20 0.31
GABRD O14764 2/20 0.31
GABRA1 P14867 2/20 0.31
GABRB1 P18505 2/20 0.31
GABRG2 P18507 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28936397 0.81 CHRM1 (0.41) CYP1A2MEN1ALDH1A1THRBKMT2A
SCHEMBL11723613 0.81 GRM2 (0.34) CYP1A2MEN1ALDH1A1THRBKMT2A
SCHEMBL2163518 0.80 CYP1A2 (0.40) CYP1A2MEN1ALDH1A1THRBKMT2A
SCHEMBL8768546 0.80 CYP1A2 (0.33) CYP1A2MEN1ALDH1A1THRBKMT2A
SCHEMBL9829183 0.80 CYP1A2 (0.40) CYP1A2MEN1ALDH1A1THRBKMT2A
SCHEMBL31148325 0.80 ARG1 (0.37) CYP1A2MEN1ALDH1A1THRBKMT2A
SCHEMBL9829180 0.80 CYP1A2 (0.40) CYP1A2MEN1ALDH1A1THRBKMT2A
SCHEMBL162434 0.78 ALDH1A1 (0.34) CYP1A2MEN1ALDH1A1THRBKMT2A
SCHEMBL22636108 0.78 ALDH1A1 (0.34) CYP1A2MEN1ALDH1A1THRBKMT2A
SCHEMBL20854287 0.78 ALDH1A1 (0.34) CYP1A2MEN1ALDH1A1THRBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1261611-A2 INHIBITORS OF HEPATITIS C VIRUS NS3 PROTEASE Bristol-Myers Squibb Pharma Company (US) 2002-12-04 EP disclosed
EP-1252178-A1 ALPHA-KETOAMIDE INHIBITORS OF HEPATITIS C VIRUS NS3 PROTEASE Bristol-Myers Squibb Pharma Company (US) 2002-10-30 EP disclosed
EP-1196436-A2 PEPTIDE BORONIC ACID INHIBITORS OF HEPATITIS C VIRUS PROTEASE Bristol-Myers Squibb Pharma Company (US) 2002-04-17 EP disclosed
WO-2001064678-A2 INHIBITORS OF HEPATITIS C VIRUS NS3 PROTEASE BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2001-09-07 WO disclosed
WO-2001040262-A1 ALPHA-KETOAMIDE INHIBITORS OF HEPATITIS C VIRUS NS3 PROTEASE BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2001-06-07 WO disclosed
WO-2001002424-A2 PEPTIDE BORONIC ACID INHIBITORS OF HEPATITIS C VIRUS PROTEASE DU PONT PHARMACEUTICALS COMPANY (US) 2001-01-11 WO disclosed